Table 1 Patient characteristics
Patient | Age | Gender | Diagnosis | Status | Evaluable? | Prior Doxo |
|---|---|---|---|---|---|---|
1 | 19 | M | Mesenchymal Chondrosarcoma | RR 1 | N | Y |
2 | 43 | F | MFH | RR 1 | Y | Y |
3 | 39 | F | Leiomyosarcoma | Relapse 2 | Y | Y |
4 | 18 | M | Rhabdomyosarcoma | Relapse 1 | Y | N |
5 | 9 | F | Rhabdomyosarcoma | RR 2 | Y | N |
6 | 20 | F | Rhabdomyosarcoma | Relapse 1 | N | Y |
7 | 63 | F | Leiomyosarcoma | Relapse 2 | Y | Y |
8 | 21 | M | Rhabdomyosarcoma | RR 1 | Y | Y |
9 | 70 | M | Spindle Cell Sarcoma | Relapse 2 | Y | N |
10 | 59 | F | Leiomyosarcoma | RR 1 | Y | Y |
11 | 57 | F | Chondrosarcoma | Mult Relapse | Y | N |
12 | 10 | M | Osteosarcoma | RR 1 | Y | Y |
13 | 43 | F | Clear Cell Sarcoma | Relapse 2 | Y | N |
14 | 16 | M | Ewing Sarcoma | RR 1 | Y | Y |
15 | 68 | F | Leiomyosarcoma | RR 1 | N | N |
16 | 57 | F | Synovial Sarcoma | RR 2 | Y | Y |
17 | 22 | F | Mesenchymal Chondrosarcoma | Relapse 2 | Y | Y |
18 | 32 | M | MPNST | Relapse 2 | Y | Y |
19 | 20 | F | HGUPS | RR 1 | Y | Y |
20 | 21 | F | Epithelioid Sarcoma | Relapse 1 | Y | Y |
21 | 42 | M | Rhabdomyosarcoma | Refractory | Y | N |